Global Implantable Cardiac/Heart Pacemaker Market Report By Product Type(Single & Dual Chamber Pacemaker, Biventricular Pacemaker), By Applications(Arrhythmia, Long QT Syndrome, Tachycardia, Bradycardia, Atrial fibrillation, Heart Block), Forecast Period 2017-2025

Global Implantable Cardiac Pacemaker Market Analysis, 2017-2025

Market Highlights

Recent advances in such technology have led to simpler implantation techniques, greater patient convenience with smaller device sizes, extended battery longevity, increased device safety and reliability, and improved clinical outcomes. Such improvements are gaining significant traction of numerous market players of implantable cardiac pacemakers with inexpensive costs, which in turn are projected to drive growth of implantable cardiac pacemakers market. For instance, in 2017, Abbott received the Food and Drug Administration (FDA) sanction for its MR-conditional labeling for both of its products i.e. Assurity MRI pacemaker and the Tendril MRI pacing lead. Additionally, introduction of advance technology such as wireless and automated pacemaker monitoring are achieving significant traction among healthcare providers.

Also, growing incidence of heart diseases is anticipated to boost growth of the implantable cardiac pacemakers market over the forecast period. According to the Centers for Disease Control and Prevention (CDC), 2017 data findings, Atrial Fibrillation (AFib or AF) is most common type of heart arrhythmia, which affected an estimated 2.7 to 6.1 million people in the U.S. and the number is likely to rise in near future. Furthermore, according to the data published in the Journal of the Formosan Medical Association, in 2016, around 72 million people by 2050 are expected to suffer from AF patients in Asia, which is projected to be more than double the combined numbers of patients from Europe and the U.S.

According to the report, the Cardiac Pacemakers Market is projected to reach a value of USD 8.3 billion at a CAGR of 7.1%, and in terms of volume, is predicted to exceed 2.6 mn between 2017 and 2025, the period of forecast.

Key Players Mentioned In the Report

Medtronic plc, BIOTRONIK, Inc., Boston Scientific Corporation, Jude Medical, Vitatron Holding B.V., Shree Pacetronix Ltd., MEDICO S.p.A., Lepu Medical Technology Co Ltd., LivaNova PLC and Qinming Medical

Market Segmentation

By Product Type

• Single Chamber Pacemaker
• Dual Chamber Pacemaker
• Biventricular Pacemaker

 By Applications

• Arrhythmia
• Long QT Syndrome
• Tachycardia
• Bradycardia
• Atrial fibrillation
• Heart Block
• Others

 By End Users

• Hospitals
• Emergency Care Centers

North America to Acquire Almost 32% Share of Total Implantable cardiac pacemaker Market By 2025

Based on geography, North America is expected to dominate the market followed by Europe during the forecast period. Dominance of North America is majorly attributed to the advanced healthcare infrastructure and dominance in global healthcare IT industry. Moreover, US will maintain its dominance in North America over the forecast period. Further, Asia Pacific region and other developing nations are likely to emerge as the area with maximum growth potential owing to focus of key players in emerging economies and improving healthcare infrastructure.

For a full detailed overview, send us the sample request.

Key Questions Answered In This Global Implantable Cardiac Pacemaker Market Report

• What is the total market size by 2025 and what would be the expected growth rate of market?
• What is the total revenue per segment and region in 2016-17 and what would be the expected revenue per segment and region over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

Reasons to buy this market study

• Facilitate decision-making based on strong historic and forecast data for implantable cardiac pacemaker market
• Develop strategies based on the latest regulatory framework
• Position yourself to gain the maximum advantage of the implantable cardiac pacemaker market’s growth potential
• Identify key partners and business development avenues across the globe
• Respond to your competitors’ business structure, strategy and prospects